Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development

Caroline J Jjingo, Shukal Bala, Ursula Waack, Mark Needles, Timothy J Bensman, Owen McMaster, Thomas Smith, Brandon Blakely, Irene Z Chan, Khalid Puthawala, Cheryl Dixon, Yongman Kim, Robert Lim, Philip Colangelo, Christopher St. Clair, Sumathi Nambiar, Richard B Moss, Radu Botgros, Rohit Bazaz, David W Denning, Kieren A Marr, Shahid Husain, Lance Berman, Dale J Christensen, Charlotte Keywood, Russell G Clayton, Thomas J Walsh, Hyo Sook E Song, Sunita J Shukla, John Farley

Open source

DOI
10.1093/cid/ciad607
Published
2023-10-06
Container
Clinical Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/cid/ciad607,
  title = {Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development},
  author = {Caroline J Jjingo and Shukal Bala and Ursula Waack and Mark Needles and Timothy J Bensman and Owen McMaster and Thomas Smith and Brandon Blakely and Irene Z Chan and Khalid Puthawala and Cheryl Dixon and Yongman Kim and Robert Lim and Philip Colangelo and Christopher St. Clair and Sumathi Nambiar and Richard B Moss and Radu Botgros and Rohit Bazaz and David W Denning and Kieren A Marr and Shahid Husain and Lance Berman and Dale J Christensen and Charlotte Keywood and Russell G Clayton and Thomas J Walsh and Hyo Sook E Song and Sunita J Shukla and John Farley},
  year = {2023},
  journal = {Clinical Infectious Diseases},
  doi = {10.1093/cid/ciad607},
  url = {https://doi.org/10.1093/cid/ciad607}
}

RIS

TY  - JOUR
TI  - Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development
AU  - Caroline J Jjingo
AU  - Shukal Bala
AU  - Ursula Waack
AU  - Mark Needles
AU  - Timothy J Bensman
AU  - Owen McMaster
AU  - Thomas Smith
AU  - Brandon Blakely
AU  - Irene Z Chan
AU  - Khalid Puthawala
AU  - Cheryl Dixon
AU  - Yongman Kim
AU  - Robert Lim
AU  - Philip Colangelo
AU  - Christopher St. Clair
AU  - Sumathi Nambiar
AU  - Richard B Moss
AU  - Radu Botgros
AU  - Rohit Bazaz
AU  - David W Denning
AU  - Kieren A Marr
AU  - Shahid Husain
AU  - Lance Berman
AU  - Dale J Christensen
AU  - Charlotte Keywood
AU  - Russell G Clayton
AU  - Thomas J Walsh
AU  - Hyo Sook E Song
AU  - Sunita J Shukla
AU  - John Farley
PY  - 2023
JO  - Clinical Infectious Diseases
DO  - 10.1093/cid/ciad607
UR  - https://doi.org/10.1093/cid/ciad607
ER  - 

APA

Jjingo, C. J., Bala, S., Waack, U., Needles, M., Bensman, T. J., McMaster, O., Smith, T., Blakely, B., Chan, I. Z., Puthawala, K., Dixon, C., Kim, Y., Lim, R., Colangelo, P., Clair, C. S., Nambiar, S., Moss, R. B., Botgros, R., Bazaz, R., Denning, D. W., Marr, K. A., Husain, S., Berman, L., Christensen, D. J., Keywood, C., Clayton, R. G., Walsh, T. J., Song, H. S. E., Shukla, S. J., & Farley, J. (2023). Food and Drug Administration Public Workshop Summary—Addressing Challenges in Inhaled Antifungal Drug Development. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciad607

Source records